Table 3
Values of clinical objective indicators in patients with chronic obstructive pulmonary disease
| Clinical objective indicator | Number | Range | Average (
±s) | Minimum | Maximum |
| TP (g/L) | 260 | 60–82 | 64.61±7.07 | 49.00 | 112.60 |
| ALB (g/L) | 260 | 35–54 | 35.65±4.93 | 20.70 | 49.20 |
| TBA (μmol/L) | 194 | 0–15 | 7.45±10.09 | 0.10 | 70.00 |
| ALP (IU/L) | 196 | 31–115 | 75.00±24.87 | 38.70 | 176.00 |
| Scr (μmol/L) | 260 | 42–97 | 77.89±30.00 | 33.00 | 272.00 |
| K (mmol/L) | 260 | 3.5–5.5 | 4.03±0.48 | 2.68 | 5.55 |
| Na (μmol/L) | 260 | 136–146 | 140.00±3.84 | 118.50 | 151.60 |
| NEUT% | 259 | 50–70 | 72.02±12.76 | 40.00 | 96.70 |
| LYMPH% | 259 | 20–40 | 18.34±10.14 | 0.90 | 48.40 |
| MONO% | 258 | 3–10 | 7.90±4.03 | 0.10 | 27.60 |
| LYMPH (109/L) | 259 | 0.8–4 | 1.36±0.75 | 0.23 | 4.91 |
| MONO (109/L) | 258 | 0.12–1.0 | 0.64±10.57 | 0.00 | 3.91 |
| HCT (%) | 257 | 33.5–45 | 41.01±7.98 | 17.40 | 68.30 |
| PCO2 (mm Hg) | 205 | 35–45 | 52.28±11.33 | 24.00 | 89.00 |
| FVC (L) | 153 | 2.31–3.18 | 2.26±0.46 | 1.06 | 3.66 |
| FEV1 (L) | 152 | 2.31–3.18 | 1.23±0.37 | 0.43 | 2.71 |
| CRP (mg/L) | 212 | ≤10 | 33.24±26.77 | 1.25 | 128.00 |
ALB, albumin ; ALP, alkaline phosphatase; CRP, C-reactive protein; FEV1, 1-second forced expiratory volume; FVC, forced vital capacity; HCT, hematocrit ; K, serum potassium; LYMPH, lymphocytes; LYMPH%, percentage of lymphocytes; MONO%, percentage of monocytes; Na, serum sodium; NEUT%, percentage of neutrophils; PCO2, partial pressure of carbon dioxide; Scr, creatinine; TBA, total bile acid; TP, total protein.